Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
RDY compared with NVS: revenue, margins and what each company keeps, and the suppliers and customers both name
RDY
DR Reddys Laboratories Ltd
Change
Mkt cap
Revenue
Revenue
NVS
Novartis AG
Change
Mkt cap
Revenue
Revenue
vs
Compare
RDY
DR Reddys Laboratories Ltd
vs
NVS
Novartis AG
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
RDY: latest quarter not drawable. NVS: latest quarter not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
RDY, solid
NVS, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only RDY
6
RIGL
Rigel Pharmaceuticals
supplier
COYA
Coya Therapeutics
supplier
CTOR
Citius Oncology
customer
ALVO
Alvotech
supplier
2 more · RDY chain
›
Shared
0
No shared counterparties.
Only NVS
21
REGN
Regeneron Pharmaceuticals
supplier
VEEV
Veeva Systems
supplier
ARWR
Arrowhead Pharmaceuticals
supplier
PTCT
PTC Therapeutics
Role chip = supplier or customer
Source: SEC EDGAR
supplier
17 more · NVS chain
›
RDY
DR Reddys Laboratories Ltd
Change
14.73
▲
+3.01%
Mkt cap
$11.9B
NVS
Novartis AG
Change
164.58
▲
+3.34%
Regular session
Nov 4 '26
Mkt cap
$303.9B
vs
Compare
Regular session
Nov 4 '26
RDY
DR Reddys Laboratories Ltd
vs
NVS
Novartis AG
14.73
▲
+3.01%
Price
164.58
▲
+3.34%
$11.9B
Mkt cap
$303.9B
Change
Change
RDY
14.73
▲
+3.01%
vs
NVS
164.58
▲
+3.34%
Regular session
Nov 4 '26